Status:
NOT_YET_RECRUITING
Effects of Levetiracetam Monotherapy on Various Hematological Parameters in Adult Patients Suffering of Epilepsy
Lead Sponsor:
Assiut University
Conditions:
Neutropenia
Thrombocytopenia
Eligibility:
All Genders
18-60 years
Brief Summary
Low therapeutic index of established antiepileptic drugs (AEDs) coupled with better understanding of the pathophysiology of seizure has encouraged the development of several novel AEDs. The convention...
Detailed Description
Epilepsy is a chronic neurologic disease that is considered the most common neurological diseases in the world and comes third after cerebrovascular and Alzheimer's disease. Epilepsy is a disorder cha...
Eligibility Criteria
Inclusion
- Adult Epileptic patients of both genders aged \>18 years on mono-therapy of levetiracetam anti-epileptic drug treatment for at least six months.
Exclusion
- Patients were on treatment for less than six months.
- Patients had other conditions besides epilepsy that could affect blood parameters.
- patients on treatment with other antiepileptic medications besides levetiracetam.
Key Trial Info
Start Date :
November 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06491303
Start Date
November 1 2024
End Date
December 1 2025
Last Update
July 9 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.